Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma
Jeffrey C. Rathmell(Vanderbilt University Medical Center), Craig B. Thompson(Memorial Sloan Kettering Cancer Center)
Cited by 194
Related Papers
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
|Journal of Clinical Investigation|2007|1.1k
Tumor suppressors and cell metabolism: a recipe for cancer growth
|Genes & Development|2009|1.1k
Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth
|Cancer Research|2007|917
Necrotic death as a cell fate
|Genes & Development|2006|901